Chattem R&D
This article was originally published in The Tan Sheet
Executive Summary
Donald Riker, PhD, named VP-R&D and chief scientific officer, replacing former R&D head Elaine Morefield, PhD, who left in July to pursue other interests. Riker brings almost 20 years experience in clinical-regulatory affairs, licensing and OTC product development at P&G and Richardson-Vicks, working on such brands as NyQuil, DayQuil, Vicks VapoRub and Formula 44. He has served as associate director and P&G Fellow at Procter's global healthcare facility in Mason, Ohio, since 1992. Chattem says creation of CSO post signals greater emphasis on R&D...